Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Connection

Search Results to

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of Irreversible myelosuppression after fludarabine-melphalan conditioning: observations in patients with graft rejection.

PropertyValue
has major subject area list Antineoplastic Agents, Alkylating; Graft Rejection; Immunosuppressive Agents; Melphalan; Vidarabine
information resource reference Van Besien K, Smith S, Anastasi J, Larson R, Thirman M, Odenike T, Stock W. Irreversible myelosuppression after fludarabine-melphalan conditioning: observations in patients with graft rejection. Blood. 2004 Jun 01; 103(11):4373-4.
label Irreversible myelosuppression after fludarabine-melphalan conditioning: observations in patients with graft rejection.

Search Criteria
  • Transplant Rejection